Related Experiment Video
Updated: Jun 19, 2026
06:39
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
Pharmacotherapy of postpartum depression
Teresa Lanza di Scalea1, Katherine L Wisner
1Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. lanzadiscaleat@upmc.edu
Expert Opinion on Pharmacotherapy
|October 31, 2009
Summary
Postpartum depression (PPD) affects 13% of mothers. While antidepressants and hormonal supplements show potential for PPD treatment and prevention, personalized risk-benefit analysis is crucial for selecting effective therapies.
Area of Science:
- Reproductive Psychiatry
- Pharmacology
- Maternal-Infant Health
Background:
- Postpartum depression (PPD) affects 13% of mothers, with a 25% recurrence rate.
- PPD significantly impacts maternal and infant well-being.
- Limited data exists on the efficacy of pharmacological PPD treatments.
Purpose of the Study:
- Review literature on antidepressants and hormonal supplements for PPD prevention and treatment.
- Provide expert opinion on the current state of pharmacological PPD management.
- Discuss future developments in PPD pharmacotherapy.
Main Methods:
- Conducted an electronic literature search using PubMed, Medline, and PsychINFO.
- Included empirical, peer-reviewed, English-language articles.
- Focused on studies with validated depression measures and uniform scoring.
Main Results:
- Identified 19 relevant articles: 12 on treatment and 7 on prevention.
- Studies included 8 randomized clinical trials and 11 open-label studies.
- Evidence synthesis for various pharmacological interventions.
Conclusions:
- Pharmacological interventions, including antidepressants and hormonal supplements, are explored for PPD.
- Personalized risk-benefit assessment is essential for choosing PPD treatments.
- Future research directions in PPD pharmacotherapy are highlighted.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...